Interestingly, A549 NSCLC are p53 wild-type and MDM2-overexpressed cells: various evidence suggest that MDM2 inhibition could enhance radiosensitivity [57] or act as a chemosensitizing agent to etoposide [58] . Here, MDM2 is linked to non-small cell lung carcinoma.